Straka RJ - Search Results

1

Profiling circulating and urinary bile acids in patients with biliary obstruction before and after biliary stenting.

Trottier J, Białek A, Caron P, Straka RJ, Milkiewicz P, Barbier O. Trottier J, et al. Among authors: straka rj. PLoS One. 2011;6(7):e22094. doi: 10.1371/journal.pone.0022094. Epub 2011 Jul 8. PLoS One. 2011. PMID: 21760958 Free PMC article.

2

In vitro glucuronidation of fenofibric acid by human UDP-glucuronosyltransferases and liver microsomes.

Tojcic J, Benoit-Biancamano MO, Court MH, Straka RJ, Caron P, Guillemette C. Tojcic J, et al. Among authors: straka rj. Drug Metab Dispos. 2009 Nov;37(11):2236-43. doi: 10.1124/dmd.109.029058. Epub 2009 Aug 6. Drug Metab Dispos. 2009. PMID: 19661212 Free PMC article.

3

Profile of serum bile acids in noncholestatic volunteers: gender-related differences in response to fenofibrate.

Trottier J, Caron P, Straka RJ, Barbier O. Trottier J, et al. Among authors: straka rj. Clin Pharmacol Ther. 2011 Aug;90(2):279-86. doi: 10.1038/clpt.2011.124. Epub 2011 Jun 29. Clin Pharmacol Ther. 2011. PMID: 21716269 Free PMC article. Clinical Trial.

4

Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study.

Trottier J, Białek A, Caron P, Straka RJ, Heathcote J, Milkiewicz P, Barbier O. Trottier J, et al. Among authors: straka rj. Dig Liver Dis. 2012 Apr;44(4):303-10. doi: 10.1016/j.dld.2011.10.025. Epub 2011 Dec 9. Dig Liver Dis. 2012. PMID: 22169272

5

Profiling serum bile acid glucuronides in humans: gender divergences, genetic determinants, and response to fenofibrate.

Trottier J, Perreault M, Rudkowska I, Levy C, Dallaire-Theroux A, Verreault M, Caron P, Staels B, Vohl MC, Straka RJ, Barbier O. Trottier J, et al. Among authors: straka rj. Clin Pharmacol Ther. 2013 Oct;94(4):533-43. doi: 10.1038/clpt.2013.122. Epub 2013 Jun 12. Clin Pharmacol Ther. 2013. PMID: 23756370 Free PMC article. Clinical Trial.

6

The effect of CYP7A1 polymorphisms on lipid responses to fenofibrate.

Shen J, Arnett DK, Parnell LD, Lai CQ, Straka RJ, Hopkins PN, An P, Feitosa MF, Ordovás JM. Shen J, et al. Among authors: straka rj. J Cardiovasc Pharmacol. 2012 Mar;59(3):254-9. doi: 10.1097/FJC.0b013e31823de86b. J Cardiovasc Pharmacol. 2012. PMID: 22075751 Free PMC article. Clinical Trial.

7

Determination of fenofibric acid concentrations by HPLC after anion exchange solid-phase extraction from human serum.

Straka RJ, Burkhardt RT, Fisher JE. Straka RJ, et al. Ther Drug Monit. 2007 Apr;29(2):197-202. doi: 10.1097/ftd.0b013e318030860a. Ther Drug Monit. 2007. PMID: 17417074

8

Comparison of the prevalence of the poor metabolizer phenotype for CYP2D6 between 203 Hmong subjects and 280 white subjects residing in Minnesota.

Straka RJ, Hansen SR, Walker PF. Straka RJ, et al. Clin Pharmacol Ther. 1995 Jul;58(1):29-34. doi: 10.1016/0009-9236(95)90069-1. Clin Pharmacol Ther. 1995. PMID: 7628180

9

Fenofibrate and metabolic syndrome.

Kraja AT, Province MA, Straka RJ, Ordovas JM, Borecki IB, Arnett DK. Kraja AT, et al. Among authors: straka rj. Endocr Metab Immune Disord Drug Targets. 2010 Jun;10(2):138-48. doi: 10.2174/187153010791213047. Endocr Metab Immune Disord Drug Targets. 2010. PMID: 20406163 Free PMC article. Review.

10

Rare PPARA variants and extreme response to fenofibrate in the Genetics of Lipid-Lowering Drugs and Diet Network Study.

Irvin MR, Zhang Q, Kabagambe EK, Perry RT, Straka RJ, Tiwari HK, Borecki IB, Shimmin LC, Stuart C, Zhong Y, Hixson JE, Arnett DK. Irvin MR, et al. Among authors: straka rj. Pharmacogenet Genomics. 2012 May;22(5):367-72. doi: 10.1097/FPC.0b013e328351a486. Pharmacogenet Genomics. 2012. PMID: 22336959 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page